Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans (Q56888747)

No description defined

Cutting edge: CTLA-4 on effector T cells inhibits in trans

Language	Label	Description	Also known as
English	Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans	No description defined	Cutting edge: CTLA-4 on effector T cells inhibits in trans

Statements

instance of

scholarly article

0 references

title

Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans (English)

0 references

Cutting edge: CTLA-4 on effector T cells inhibits in trans (English)

0 references

2

James P Allison

0 references

author name string

E. Corse

series ordinal

1

0 references

J. P. Allison

series ordinal

2

0 references

Emily Corse

series ordinal

1

0 references

language of work or name

English

0 references

publication date

2 July 2012

0 references

1 August 2012

0 references

published in

Journal of Immunology

0 references

volume

189

0 references

page(s)

1123-1127

0 references

1123-7

0 references

issue

3

0 references

cites work

CTLA-4 can function as a negative regulator of T cell activation

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/1074-7613(94)90071-X

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Thymocyte development is normal in CTLA-4-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Novel cancer immunotherapy agents with survival benefit: recent successes and next steps

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

CTLA-4 control over Foxp3+ regulatory T cell function

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Ligand recognition by alpha beta T cell receptors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

CD28 and CTLA-4 coreceptor expression and signal transduction

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Cutting edge: cell-extrinsic immune regulation by CTLA-4 expressed on conventional T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Attenuated T cell responses to a high-potency ligand in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

CTLA-4: not all costimulation is stimulatory

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.4049/JIMMUNOL.1200695

Identifiers

DOI

10.4049/JIMMUNOL.1200695

0 references

PubMed ID

22753941

0 references

Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans (Q56888747)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans (Q56888747)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search